Mendenhall NP - Search Results

1

Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience.

Karayalcin G, Behm FG, Gieser PW, Kung F, Weiner M, Tebbi CK, Ferree C, Marcus R, Constine L, Mendenhall NP, Chauvenet A, Murphy SB. Karayalcin G, et al. Among authors: mendenhall np. Med Pediatr Oncol. 1997 Dec;29(6):519-25. doi: 10.1002/(sici)1096-911x(199712)29:6<519::aid-mpo1>3.0.co;2-n. Med Pediatr Oncol. 1997. PMID: 9324338

2

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL. Tebbi CK, et al. Among authors: mendenhall np. J Clin Oncol. 2007 Feb 10;25(5):493-500. doi: 10.1200/JCO.2005.02.3879. J Clin Oncol. 2007. PMID: 17290056 Clinical Trial.

3

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group.

Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A. Tebbi CK, et al. Among authors: mendenhall np. Pediatr Blood Cancer. 2012 Dec 15;59(7):1259-65. doi: 10.1002/pbc.24279. Epub 2012 Aug 21. Pediatr Blood Cancer. 2012. PMID: 22911615 Free PMC article. Clinical Trial.

4

With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study.

Mendenhall NP, Cantor AB, Williams JL, Ternberg JL, Weiner MA, Kung FH, Marcus RB Jr, Ferree CR, Leventhal BG. Mendenhall NP, et al. J Clin Oncol. 1993 Nov;11(11):2218-25. doi: 10.1200/JCO.1993.11.11.2218. J Clin Oncol. 1993. PMID: 8229137

5

The impact of pelvic recurrence and elective pelvic irradiation on survival and treatment morbidity in early-stage Hodgkin's disease.

Mendenhall NP, Taylor BW Jr, Marcus RB Jr, Million RR. Mendenhall NP, et al. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1157-65. doi: 10.1016/0360-3016(91)90271-5. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938513 Clinical Trial.

6

The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.

Kamath SS, Marcus RB Jr, Lynch JW, Mendenhall NP. Kamath SS, et al. Among authors: mendenhall np. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):563-8. doi: 10.1016/s0360-3016(99)00051-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348285

7

The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.

Mendenhall NP, Rodrigue LL, Moore-Higgs GJ, Marcus RB Jr, Million RR. Mendenhall NP, et al. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):551-61. doi: 10.1016/s0360-3016(99)00087-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348284

8

High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors.

Kedar A, Maria BL, Graham-Pole J, Ringdahl DM, Quisling RG, Mickle JP, Mendenhall NP, Marcus RB Jr, Gross S. Kedar A, et al. Among authors: mendenhall np. Med Pediatr Oncol. 1994;23(5):428-36. doi: 10.1002/mpo.2950230507. Med Pediatr Oncol. 1994. PMID: 8084310 Clinical Trial.

9

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS; Expert Panel on Radiation OncologyLymphoma. Roberts KB, et al. Among authors: mendenhall np. Am J Clin Oncol. 2016 Aug;39(4):384-95. doi: 10.1097/COC.0000000000000294. Am J Clin Oncol. 2016. PMID: 27299425 Review.

10

Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.

Bates JE, Parikh RR, Mendenhall NP, Morris CG, Hoppe RT, Constine LS, Hoppe BS. Bates JE, et al. Among authors: mendenhall np. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):522-529. doi: 10.1016/j.ijrobp.2020.02.642. Epub 2020 Mar 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32173399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters